Patent · US Active

Methods and nucleic acids for determining the prognosis of a cancer subject

US11261499B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

EPIGENOMICS AG · DE

Inventors

Jörn LEWIN · Berlin, DE
Manuel Krispin · Berlin, DE

Key dates

Filing date	Mar 10, 2020
Grant date	Mar 1, 2022
Priority date	—
Expiry date	Mar 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/154
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods, nucleic acids and kits for determining the prognosis of a subject having cancer. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.